© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
Author | Tony Berberabe, MPH
Articles
JNJ-4528 Continues to Show Durable Responses in Relapsed/Refractory Multiple Myeloma
June 07, 2020
The CAR T-cell therapy continued to demonstrate deep and durable responses in heavily pretreated patients with relapsed/refractory multiple myeloma.